Navigation Links
Hidden heart condition increases the risk of death in patients waiting for kidney transplants
Date:5/15/2008

Washington, DC (Thursday, May 15, 2008) An often asymptomatic conditionsystolic dysfunction, or decreased pumping of the heartposes an increased risk of death for patients on kidney transplant waiting lists, according to a study appearing in the June 2008 issue of the Journal of the American Society Nephrology (JASN). The findings reveal that a clinical indicator beyond well-known risk factors for cardiovascular mortality should be considered when caring for patients waiting for kidney donations. The study also suggests that changes in organ allocation policies may be warranted.

Previous research has shown that patients with chronic kidney disease face an elevated risk of dying from heart conditions, such as cardiac ischemia, which occurs when the heart receives an insufficient supply of blood and oxygen. However, ischemic events do not account for most of the cardiac deaths that have been reported in these patients.

To determine what other heart effects may be playing a role in the deaths of patients with chronic kidney disease, Dr. Angelo M. de Mattos, an associate professor of nephrology at the University of California, Davis, School of Medicine and Medical Center in Sacramento, Calif., and colleagues at the University of Alabama at Birmingham analyzed the records for 2,718 kidney transplant candidates, noting the causes of death in those who died. During the study, 681 patients died during follow-up, which was conducted for a median of 27 months.

The investigators discovered that patients with systolic dysfunction were nearly twice as likely to die as those without this condition. This higher rate of mortality was similar to that seen in patients with cardiac ischemia, the most well-known risk factor for cardiovascular death in patients with chronic kidney disease.

Dr. de Mattos and his team found that death rates for patients with systolic dysfunction who were waiting for kidney transplants were almost six-fold higher than the reported mortality for individuals with systolic dysfunction in the general population.

The study identifies a subset of the chronic kidney disease population (those with systolic dysfunction, with or without ischemia) at significantly higher mortality risk while awaiting transplantation, where the role of medical interventions and devices such as implantable cardiac defibrillators and pacemakers should be studied, the authors write. Widely available and minimally invasive testing could be used to help identify those patients with chronic kidney disease who have this mostly asymptomatic, yet life-threatening, condition.

The authors note that if their findings are supported by additional studies, organ distribution policies may need to be redesigned so as to place a priority on these individuals who traditionally have not been considered at an increased risk of death.


'/>"/>

Contact: Shari Leventhal
sleventhal@asn-online.org
202-416-0658
American Society of Nephrology
Source:Eurekalert  

Related medicine news :

1. New AnyTrack GPS Devices Track Assets Indoors, Outdoors or Hidden
2. Fetal cell transplant could be a hidden link between childbirth and reduced risk of breast cancer
3. Vanda Pharmaceuticals to Present at Natixis Bleichroeders Hidden Gems Conference
4. National Geographic Channel, Ashley Judd and YouthAIDS Host World Premiere Screening of Indias Hidden Plague
5. Video Pill Spots Hidden Crohns Disease
6. California Wildfires - The Hidden Dangers & Actions You Can Take
7. Brain MRIs Find Hidden Neurological Problems
8. Hidden Costs Plague Owners Occupying Newly Constructed Buildings; New Program Can Help Avoid Major Issues
9. Protect Pets From Winters Hidden Dangers
10. Hidden Veggies on the go hits Whole Foods Market(R) in 2008
11. Routine screenings uncover hidden carbon monoxide poisoning
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hidden heart condition increases the risk of death in patients waiting for kidney transplants
(Date:3/23/2017)... , ... March 23, 2017 , ... The MBI “Hall of Fame” recognizes the contributions ... have had a significant impact on the careers of all others involved. , ... was inducted into the MBI’s Hall of Fame. The induction took place during the ...
(Date:3/23/2017)... ... March 23, 2017 , ... March is National Kidney ... a punch when it comes to maintaining good health. Every day, two kidneys filter ... kidneys filter every drop of your blood, eliminating waste, regulating fluid levels and blood ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... in Los Angeles based healthcare technology company California Healthcom Group (CHG). , ... US, and healthcare arena. With headquarters in California, CHG is a growing, internationally ...
(Date:3/23/2017)... ... March 23, 2017 , ... Michael Lanteri ... the greater Fort Collins area, has unveiled a collaboration with nonprofit Big Bones ... Donations to this worthy cause may now be made at http://bigbonescaninerescue.com/ . ...
(Date:3/23/2017)... ... 23, 2017 , ... Altec Products, Inc. , a ... their 2016 Microsoft Dynamics Partner of the Year at DocLink Evolution , ... recognizes The Resource Group for their outstanding relationship with Altec and their ability ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 2017 Research and Markets has announced the ... to their offering. ... The global capillary electrophoresis market to grow at a CAGR ... Global Capillary Electrophoresis Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:3/23/2017)... , March 23, 2017  Drug diversion is ... misuse and deadly overdoses. A new oral fluid ... www.cordantsolutions.com , reports more detailed and actionable ... can potentially improve therapy adherence, patient safety, and ... Cordant Comprehensive Oral fluid Rx Evaluation (CORE) system ...
(Date:3/23/2017)...  A new genetic test has been discovered ... who carry HLA-B*15:02 and who are ... deadly side effect of certain medications used to ... HLA-B*15:02 is strongly associated with life-threatening severe ... toxic epidermal necrolysis in patients treated with carbamazepine ...
Breaking Medicine Technology: